AllianceBernstein’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.3M | Buy |
1,388,149
+107,199
| +8% | +$4.66M | 0.02% | 555 |
|
|
2025
Q1 | $47.9M | Sell |
1,280,950
-74,235
| -5% | -$2.77M | 0.02% | 596 |
|
|
2024
Q4 | $61.4M | Buy |
1,355,185
+160,822
| +13% | +$7.29M | 0.02% | 537 |
|
|
2024
Q3 | $70.2M | Buy |
1,194,363
+62,093
| +5% | +$3.65M | 0.02% | 515 |
|
|
2024
Q2 | $44.6M | Buy |
1,132,270
+387,152
| +52% | +$15.2M | 0.02% | 629 |
|
|
2024
Q1 | $49.5M | Buy |
745,118
+734,478
| +6,903% | +$48.8M | 0.02% | 604 |
|
|
2023
Q4 | $297K | Buy |
+10,640
| New | +$297K | ﹤0.01% | 2848 |
|